Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (41)

Search Parameters:
Keywords = primate research laboratory

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 827 KB  
Article
How University Students Evaluate the Use of Laboratory Animals: The Role of Species and Individual Differences
by Leire Ruiz-Sancho, Oihane Saez-Atxukarro, Ainara Gomez-Gastiasoro and Garikoitz Azkona
Animals 2026, 16(7), 1005; https://doi.org/10.3390/ani16071005 - 25 Mar 2026
Viewed by 297
Abstract
The use of animals in biomedical research and university teaching remains socially sensitive, shaped by ethical concerns, regulations, and public expectations. While animal models are still essential for basic and translational research, society increasingly demands transparency, strong welfare protections, and the development of [...] Read more.
The use of animals in biomedical research and university teaching remains socially sensitive, shaped by ethical concerns, regulations, and public expectations. While animal models are still essential for basic and translational research, society increasingly demands transparency, strong welfare protections, and the development of alternative methods. This study investigated Spanish university students’ attitudes toward the use of animals in basic research, translational research, and educational settings, and examined their acceptance of different species for addressing human health problems. It also assessed how sociodemographic variables, personality traits, empathy, and anthropomorphism relate to these views. The sample included 653 students, predominantly women, heterosexual, and urban residents. Most participants supported the use of animals in research, whereas opinions regarding teaching uses were more divided. Attitudes toward the use of laboratory animals consistently differed by gender and field of study, with men and students in science-related disciplines showing higher acceptance. Of the psychological variables assessed, only anthropomorphism showed moderate negative correlations with support for the use of laboratory animals across all contexts. Species strongly influenced attitudes: companion animals generated the most opposition, primates and livestock elicited mixed responses, and rodents, invertebrates, and aquatic species received the highest support. Overall, students generally accept animal use but vary substantially by species, gender, and academic background. Full article
(This article belongs to the Section Animal Ethics)
Show Figures

Figure 1

8 pages, 214 KB  
Opinion
Natural Hepacivirus Infection in Tree Shrews: A Call for Routine Screening in Hepatitis Virus Research
by Mohammad Enamul Hoque Kayesh, Takahiro Sanada, Michinori Kohara and Kyoko Tsukiyama-Kohara
Viruses 2026, 18(1), 27; https://doi.org/10.3390/v18010027 - 23 Dec 2025
Viewed by 991
Abstract
Hepatitis viruses continue to pose major global health challenges, necessitating the development of reliable and well-characterized experimental models. Tree shrews are increasingly recognized as a valuable small animal model because of their natural susceptibility to hepatitis viruses and close phylogenetic relationship with primates. [...] Read more.
Hepatitis viruses continue to pose major global health challenges, necessitating the development of reliable and well-characterized experimental models. Tree shrews are increasingly recognized as a valuable small animal model because of their natural susceptibility to hepatitis viruses and close phylogenetic relationship with primates. Recent identification of a high prevalence of natural hepacivirus infections in tree shrews underscores the urgent need for routine viral screening of the animals used in hepatitis studies. Undetected infections may confound experimental results, undermine data integrity, and pose risks to laboratory biosecurity. Integrating systematic screening and standardized reporting practices will minimize these risks, enhance reproducibility, and safeguard the integrity of research findings. Moreover, a consistent assessment of the infection status will enhance the translational potential of tree shrews for studying viral hepatitis pathogenesis and evaluating antiviral interventions. This opinion paper emphasizes that ensuring the virological status of tree shrews is not merely a procedural recommendation but also a methodological standard essential for advancing hepatitis virus research. Full article
(This article belongs to the Section Animal Viruses)
15 pages, 1105 KB  
Review
The Application of Gamma-Range Auditory Steady-State Responses in Animal Models: A Semi-Structured Literature Review
by Urte Jasinskyte, Cestmir Vejmola, Robertas Guzulaitis and Inga Griskova-Bulanova
Brain Sci. 2025, 15(11), 1159; https://doi.org/10.3390/brainsci15111159 - 28 Oct 2025
Cited by 1 | Viewed by 1274
Abstract
Background: Gamma-range auditory steady-state responses (ASSRs) are emerging as promising translational biomarkers of neural network function. While extensively studied in human neuropsychiatric and neurodevelopmental research, their application in animal models has expanded in recent years, providing mechanistic insights into disease-related neural dynamics. However, [...] Read more.
Background: Gamma-range auditory steady-state responses (ASSRs) are emerging as promising translational biomarkers of neural network function. While extensively studied in human neuropsychiatric and neurodevelopmental research, their application in animal models has expanded in recent years, providing mechanistic insights into disease-related neural dynamics. However, methodological approaches vary widely, findings remain fragmented, and outcomes are not easily generalized. Methods: A literature search was conducted in March 2025 across PubMed and Scopus to identify studies investigating gamma-range ASSRs (30–100 Hz) in animal models with relevance to psychiatric and developmental conditions. Results: Most studies employed rodents, with a smaller number involving non-human primates, and used pharmacological, genetic, lesion-based, or developmental manipulations relevant to schizophrenia, autism spectrum disorder, and related conditions. ASSRs were highly sensitive to NMDA receptor antagonism, state- and trait-related factors, and exhibited region- and layer-specific generation patterns centered on the auditory cortex. Less common paradigms, such as chirps and gap-in-noise, also demonstrated translational potential. Conclusions: Animal research confirms that gamma-range ASSRs provide a sensitive, cross-species readout of circuit dysfunctions observed in psychiatric and neurodevelopmental disorders. To maximize their translational utility, future work should prioritize methodological harmonization, systematic inclusion of sex and behavioral state factors, and replication across laboratories. Strengthening these aspects will enhance the value of ASSRs as biomarkers for early detection, patient stratification, and treatment monitoring in clinical psychiatry. Full article
Show Figures

Figure 1

22 pages, 350 KB  
Review
Current Advances and Applications of Animal Models in SARS-CoV-2 Pathogenesis and Vaccine Development
by Li Wu, Yingying Tao, Xing Wu, Shaozhen Li, Rui Yang, Chengying Li, Yao Yao, Shijia Xu, Jianhong Shu, Yulong He and Huapeng Feng
Microorganisms 2025, 13(9), 2009; https://doi.org/10.3390/microorganisms13092009 - 28 Aug 2025
Cited by 1 | Viewed by 3018
Abstract
COVID-19 is the most widespread emerging infectious disease in humans, recently caused by the SARS-CoV-2 virus. Understanding the pathogenesis and development of efficient vaccines is crucial for the prevention and control of this emerging disease. SARS-CoV-2 viruses have widespread hosts, including humans, domesticated/companion [...] Read more.
COVID-19 is the most widespread emerging infectious disease in humans, recently caused by the SARS-CoV-2 virus. Understanding the pathogenesis and development of efficient vaccines is crucial for the prevention and control of this emerging disease. SARS-CoV-2 viruses have widespread hosts, including humans, domesticated/companion animals (cats, dogs), specific farmed animals (minks), specific wildlife (white-tailed deer), and laboratory animal models. Bats are considered the original reservoir, and pangolins may be important intermediate hosts. Suitable animal models play an important role in studying the pathogenicity and evaluation of vaccines and antiviral drugs during the preclinical stage. In this review, we summarized the animal models and potential animal models for the research of SARS-CoV-2 pathogenesis, vaccine and antiviral drugs development, including transgenic mice, cats, hamsters, nonhuman primates, ferrets, and so on. Our summary provides the important information to select the animals used for a specific purpose and facilitates the development of novel vaccines and antivirals to prevent and control COVID-19. Full article
(This article belongs to the Collection Advances in SARS-CoV-2 Infection)
11 pages, 1363 KB  
Case Report
Molecular and Microscopic Challenges in Detecting Plasmodium cynomolgi Co-Infections with Plasmodium vivax: A Case Report
by Mohd Adilin Yaacob, Raden Shamilah Radin Hisam, Nor Parina Ismail, Noor Azian Md Yusuf, Jose Miguel Rubio Muñoz, Suhana Hashim and Tam Jenn Zhueng
Pathogens 2025, 14(7), 651; https://doi.org/10.3390/pathogens14070651 - 30 Jun 2025
Viewed by 1382
Abstract
The risk of non-human primate (NHP) malaria transmission to humans is increasing, with Plasmodium knowlesi and Plasmodium cynomolgi emerging as significant zoonotic threats, particularly in Malaysia. While P. knowlesi is well-documented, P. cynomolgi infections in humans remain underreported, largely due to diagnostic challenges. [...] Read more.
The risk of non-human primate (NHP) malaria transmission to humans is increasing, with Plasmodium knowlesi and Plasmodium cynomolgi emerging as significant zoonotic threats, particularly in Malaysia. While P. knowlesi is well-documented, P. cynomolgi infections in humans remain underreported, largely due to diagnostic challenges. Routine microscopy and standard molecular diagnostic tools often misdiagnose P. cynomolgi infections as P. vivax due to morphological similarities and genetic homology. We report a new case of a human P. cynomolgi infection misdiagnosed as Plasmodium vivax in a 32-year-old male with no prior malaria history or travel to endemic countries. The initial diagnoses made by the microscopy and qPCR conducted by the Kota Bharu Public Health Laboratory in Kelantan identified the infection as P. vivax. However, cross-examination by the Institute for Medical Research (IMR) revealed the presence of mixed-species infection, prompting further analysis. The real-time PCR and sequencing performed at MAPELAB, Spain, confirmed the co-infection of P. vivax and P. cynomolgi. This case highlights the diagnostic limitations in detecting P. cynomolgi, which shares high genetic similarity with P. vivax, leading to potential cross-reactivity and diagnostic inaccuracies. As P. cynomolgi emerges as the second zoonotic malaria species after P. knowlesi capable of infecting humans in Southeast Asia, improved diagnostic methods are urgently needed. Enhanced molecular diagnostics and comprehensive epidemiological studies are essential to elucidate transmission dynamics, assess public health implications, and inform effective malaria control strategies. Full article
(This article belongs to the Special Issue Parasites and Zoonotic Diseases)
Show Figures

Figure 1

17 pages, 2400 KB  
Article
Generation of a Transgenic Plasmodium cynomolgi Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Testing P. vivax CSP-Based Malaria Vaccines in Non-Human Primates
by Maya Aleshnick, Shreeya Hegde, Charlie Jennison, Sebastian A. Mikolajczak, Ashley M. Vaughan, Derek Haumpy, Thomas Martinson, Judith Straimer and Brandon K. Wilder
Vaccines 2025, 13(5), 536; https://doi.org/10.3390/vaccines13050536 - 17 May 2025
Viewed by 1878
Abstract
Background/Objectives: Malaria, caused by infection with Plasmodium parasites, exacts a heavy toll worldwide. There are two licensed vaccines for malaria as well as two monoclonal antibodies that have shown promising efficacy in field trials. The vaccines and monoclonal antibodies target the major [...] Read more.
Background/Objectives: Malaria, caused by infection with Plasmodium parasites, exacts a heavy toll worldwide. There are two licensed vaccines for malaria as well as two monoclonal antibodies that have shown promising efficacy in field trials. The vaccines and monoclonal antibodies target the major surface protein (circumsporozoite protein, CSP) of Plasmodium falciparum. Yet P. falciparum is only one of the four major species of Plasmodium that infect humans. Plasmodium vivax is the second leading cause of malaria, but the P. vivax vaccine and monoclonal development lags far behind that for P. falciparum owing to the lack of basic preclinical tools such as in vitro culture or mouse models that replicate the key biological features of P. vivax. Notably among these features is the ability to form dormant liver stages (hypnozoites) that reactivate and drive the majority of the P. vivax malaria burden. Plasmodium cynomolgi is a simian parasite which is genotypically very close and phenotypically similar to P. vivax; it can infect non-human primates commonly used in research and replicates many features of P. vivax, including relapsing hypnozoites. Methods: Recently, a strain of P. cynomolgi has been adapted to in vitro cultures allowing parasite transgenesis. Here, we created a transgenic P. cynomolgi parasite in which the endogenous P. cynomolgi CSP has been replaced with P. vivax CSP, with the goal of enabling the preclinical study of anti-P. vivax CSP interventions to protect against primary and relapse infections. Results: We show that the in vitro-generated transgenic Pcy[PvCSP] parasite expresses both serotypes of P. vivax CSP and retains full functionality in vivo, including the ability to transmit to laboratory-reared Anopheles mosquitoes and cause relapsing infections in rhesus macaques. To our knowledge, this is the first gene replacement in a relapsing Plasmodium species. Conclusions: This work can directly enable the in vivo development of anti-P. vivax CSP interventions and provide a blueprint for the study of relapsing malaria through reverse genetics. Full article
(This article belongs to the Special Issue Recent Advances in Malaria Vaccine Development)
Show Figures

Figure 1

26 pages, 1786 KB  
Review
Home-Cage Training for Non-Human Primates: An Opportunity to Reduce Stress and Study Natural Behavior in Neurophysiology Experiments
by Francesco Ceccarelli, Fabrizio Londei, Giulia Arena, Aldo Genovesio and Lorenzo Ferrucci
Animals 2025, 15(9), 1340; https://doi.org/10.3390/ani15091340 - 6 May 2025
Cited by 1 | Viewed by 3343
Abstract
Research involving non-human primates remains a cornerstone in fields such as biomedical research and systems neuroscience. However, the daily routines of laboratory work can induce stress in these animals, potentially compromising their well-being and the reliability of experimental outcomes. To address this, many [...] Read more.
Research involving non-human primates remains a cornerstone in fields such as biomedical research and systems neuroscience. However, the daily routines of laboratory work can induce stress in these animals, potentially compromising their well-being and the reliability of experimental outcomes. To address this, many laboratories have adopted home-cage training protocols to mitigate stress caused by routine procedures such as transport and restraint—a factor that can impact both macaque physiology and experimental validity. This review explores the primary methods and experimental setups employed in home-cage training, highlighting their potential not only to address ethical concerns surrounding animal welfare but also to reduce training time and risks for the researchers. Furthermore, by combining home-cage training with wireless recordings, it becomes possible to expand research opportunities in behavioral neurophysiology with non-human primates. This approach enables the study of various cognitive processes in more naturalistic settings, thereby increasing the ecological validity of scientific findings through innovative experimental designs that thoroughly investigate the complexity of the animals’ natural behavior. Full article
(This article belongs to the Special Issue Research Animal Welfare: Current Practices and Future Directions)
Show Figures

Figure 1

16 pages, 6966 KB  
Article
An Immunocytochemistry Method to Investigate the Translationally Active HIV Reservoir
by Guoxin Wu, Samuel H. Keller, Ryan T. Walters, Yuan Li, Jan Kristoff, Brian C. Magliaro, Paul Zuck, Tracy L. Diamond, Jill W. Maxwell, Carol Cheney, Qian Huang, Carl J. Balibar, Thomas Rush, Bonnie J. Howell and Luca Sardo
Int. J. Mol. Sci. 2025, 26(2), 682; https://doi.org/10.3390/ijms26020682 - 15 Jan 2025
Cited by 2 | Viewed by 2942
Abstract
Despite the success of combination antiretroviral therapy (cART) to suppress HIV replication, HIV persists in a long-lived reservoir that can give rise to rebounding viremia upon cART cessation. The translationally active reservoir consists of HIV-infected cells that continue to produce viral proteins even [...] Read more.
Despite the success of combination antiretroviral therapy (cART) to suppress HIV replication, HIV persists in a long-lived reservoir that can give rise to rebounding viremia upon cART cessation. The translationally active reservoir consists of HIV-infected cells that continue to produce viral proteins even in the presence of cART. These active reservoir cells are implicated in the resultant viremia upon cART cessation and likely contribute to chronic immune activation in people living with HIV (PLWH) on cART. Methodologies to quantify the active reservoir are needed. Here, an automated immunocytochemistry (ICC) assay coupled with computational image analysis to detect and quantify intracellular Gag capsid protein (CA) is described (CA-ICC). For this purpose, fixed cells were deposited on microscopy slides by the cytospin technique and stained with antibodies against CA by an automated stainer, followed by slide digitization. Nuclear staining was used to count the number of cells in the specimen, and the chromogenic signal was quantified to determine the percentage of CA-positive cells. In comparative analyses, digital ELISA, qPCR, and flow cytometry were used to validate CA-ICC. The specificity and sensitivity of CA-ICC were assessed by staining a cell line that expresses CA (MOLT IIIB) alongside a control cell line (Jurkat) devoid of this marker, as well as peripheral blood mononuclear cells (PBMCs) from HIV seronegative donors before or after ex vivo infection with an HIV laboratory strain. The sensitivity of CA-ICC was further assayed by spiking MOLT IIIB cells into uninfected Jurkat cells in limiting dilutions. In those analyses, CA-ICC could detect down to 10 CA-positive cells per million with a sensitivity superior to flow cytometry. To demonstrate the application of CA-ICC in pre-clinical research, bulk PBMCs obtained from mouse and non-human primate animal models were stained to detect HIV CA and SIV p27, respectively. The level of intracellular CA quantified by CA-ICC in PBMCs obtained from animal models was associated with plasma viral loads and cell-associated CA measured by qPCR and ELISA, respectively. The application of CA-ICC to evaluate the activity of small-molecule targeted activator of cell-kill (TACK) in clinical specimens is presented. Overall, CA-ICC offers a simple imaging method for specific and sensitive detection of CA-positive cells in bulk cell preparations. Full article
Show Figures

Figure 1

22 pages, 2615 KB  
Article
The Laboratory Opossum (Monodelphis domestica) Is a Unique Model for Research on Zika Virus: Robust Immune Response, Widespread Dissemination, and Long-Term Persistence
by André Filipe Pastor, Susan M. Mahaney, Juan Garcia, Marisol Morales, Oscar Quintanilla, Marco A. Arriaga, John M. Thomas and John L. VandeBerg
Viruses 2024, 16(12), 1847; https://doi.org/10.3390/v16121847 - 28 Nov 2024
Viewed by 2278
Abstract
The Zika virus (ZIKV) epidemic elicited a rapid commitment to the development of animal models for ZIKV research. Non-human primates (NHPs) and mice have made significant contributions to this research, but NHPs are expensive, have a long gestation period, and are available only [...] Read more.
The Zika virus (ZIKV) epidemic elicited a rapid commitment to the development of animal models for ZIKV research. Non-human primates (NHPs) and mice have made significant contributions to this research, but NHPs are expensive, have a long gestation period, and are available only in small numbers; non-genetically modified mice are resistant to infection. To address these deficiencies, we have established the laboratory opossum, Monodelphis domestica, as a small animal model that complements the mouse and monkey models. We developed and validated an indirect ELISA for measuring antibodies to ZIKV in opossums, as well as an immunohistochemistry (IHC) method to detect ZIKV NS1 protein in tissue samples. Opossum pups inoculated intracerebrally as embryos, juveniles inoculated by several routes, and mothers that cannibalized inoculated pups became persistently infected with ZIKV. The virus spread to multiple organs and persisted for up to 38 weeks (the latest endpoint of the experiments). A robust humoral immune response was mounted, and high titers of antibodies also persisted for 38 weeks. The results establish M. domestica as a natural, non-genetically modified animal model in which ZIKV persists long-term after experimental exposure and as a unique animal model for research on the immune response to ZIKV. Full article
(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
Show Figures

Graphical abstract

12 pages, 2683 KB  
Communication
Collaborating for the Successful Retirement and End-of-Life Care of Non-Human Primates in Biomedical Research
by Amanda R. Maxwell, Eric K. Hutchinson, Jaclyn V. Allen, Melissa C. Painter and Lydia M. Hopper
Vet. Sci. 2024, 11(11), 560; https://doi.org/10.3390/vetsci11110560 - 12 Nov 2024
Cited by 4 | Viewed by 2534
Abstract
Research facilities have established animal adoption programs for laboratory animals. However, adoption to private owners is not an option for non-human primates (NHPs), so their post-research life presents a unique challenge. Here, we describe a collaborative effort between laboratory animal veterinarians and behavioral [...] Read more.
Research facilities have established animal adoption programs for laboratory animals. However, adoption to private owners is not an option for non-human primates (NHPs), so their post-research life presents a unique challenge. Here, we describe a collaborative effort between laboratory animal veterinarians and behavioral management staff in retiring NHPs in place to ensure their quality of life after the completion of research projects. The success of our retirement program hinges on our collaborative efforts to manage clinical diseases such as arthritis, amyloidosis, and diarrhea; to surgically ex-plant previous research hardware; and to evaluate the animals’ behavior and temperament to ensure each individual is placed in a new group or living situation in which they are likely to be successful and to have good welfare. Implementation of a quality-of-life assessment tool for all retired animals allows all staff involved in the animals’ care to proactively and periodically assess the quality of life of these animals. The successful retirement of NHPs living in social groups is rewarding for all personnel and promotes a culture of caring. Research animal retirement is an important way for us to give back and honor the contributions these animals have made to advancing medicine. Full article
Show Figures

Figure 1

26 pages, 2898 KB  
Review
Neuroinflammatory Proteins in Huntington’s Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications
by Xinhui Li, Huichun Tong, Shuying Xu, Gongke Zhou, Tianqi Yang, Shurui Yin, Sitong Yang, Xiaojiang Li and Shihua Li
Int. J. Mol. Sci. 2024, 25(21), 11787; https://doi.org/10.3390/ijms252111787 - 2 Nov 2024
Cited by 19 | Viewed by 5960
Abstract
Huntington’s disease (HD) is a hereditary neurodegenerative disorder caused by a CAG tract expansion in the huntingtin gene (HTT). HD is characterized by involuntary movements, cognitive decline, and behavioral changes. Pathologically, patients with HD show selective striatal neuronal vulnerability at the [...] Read more.
Huntington’s disease (HD) is a hereditary neurodegenerative disorder caused by a CAG tract expansion in the huntingtin gene (HTT). HD is characterized by involuntary movements, cognitive decline, and behavioral changes. Pathologically, patients with HD show selective striatal neuronal vulnerability at the early disease stage, although the mutant protein is ubiquitously expressed. Activation of the immune system and glial cell-mediated neuroinflammatory responses are early pathological features and have been found in all neurodegenerative diseases (NDDs), including HD. However, the role of inflammation in HD, as well as its therapeutic significance, has been less extensively studied compared to other NDDs. This review highlights the significantly elevated levels of inflammatory proteins and cellular markers observed in various HD animal models and HD patient tissues, emphasizing the critical roles of microglia, astrocytes, and oligodendrocytes in mediating neuroinflammation in HD. Moreover, it expands on recent discoveries related to the peripheral immune system’s involvement in HD. Although current immunomodulatory treatments and inflammatory biomarkers for adjunctive diagnosis in HD are limited, targeting inflammation in combination with other therapies, along with comprehensive personalized treatment approaches, shows promising therapeutic potential. Full article
(This article belongs to the Special Issue New Advances of Proteins in Neuroinflammation)
Show Figures

Figure 1

10 pages, 2201 KB  
Review
Improving the Diagnosis of Autoimmune Gastritis: From Parietal Cell Antibodies to H+/K+ ATPase Antibodies
by Michela Tonegato, Maria Piera Panozzo, Antonio Antico and Nicola Bizzaro
Diagnostics 2024, 14(16), 1721; https://doi.org/10.3390/diagnostics14161721 - 8 Aug 2024
Cited by 11 | Viewed by 5351
Abstract
Parietal cell autoantibodies (PCAs), which recognize the enzyme H+/K+-ATPase as a target, are considered to be a diagnostic marker of autoimmune gastritis and pernicious anemia; these conditions are characterized by the presence of corpus atrophic gastritis. Circulating PCAs can be detected using several [...] Read more.
Parietal cell autoantibodies (PCAs), which recognize the enzyme H+/K+-ATPase as a target, are considered to be a diagnostic marker of autoimmune gastritis and pernicious anemia; these conditions are characterized by the presence of corpus atrophic gastritis. Circulating PCAs can be detected using several analytical methods that are commonly available in the clinical laboratory. Traditionally, indirect immunofluorescence (IIF) on rodent or primate stomach tissue is used as a screening test for the detection of PCAs. However, IIF suffers from a high inter-observer variability and lacks standardization. In addition, like immunoblotting, results are expressed only in a qualitative or semi-quantitative manner. Based on the few available studies that are reviewed herein, quantitative enzyme-linked immunosorbent assays (ELISAs) and fluorescence enzyme immunoassays (FEIAs) using purified H+/K+-ATPase perform better than IIF in the detection of PCAs, displaying higher sensitivity and utility in monitoring the disease. In light of their higher diagnostic accuracy, these solid-phase methods should be preferred to IIF in the screening of autoimmune atrophic gastritis. The use of methods to detect antibodies versus a specific subunit of H+/K+-ATPase (α or β) is currently confined to the world of research. Further investigation is required to define the clinical utility of H+/K+-ATPase subunit detection. Full article
(This article belongs to the Special Issue Recent Advances in Clinical Laboratory Immunology)
Show Figures

Figure 1

17 pages, 1731 KB  
Review
VDAC in Retinal Health and Disease
by Ying Xu, Shanti R. Tummala, Xiongmin Chen and Noga Vardi
Biomolecules 2024, 14(6), 654; https://doi.org/10.3390/biom14060654 - 4 Jun 2024
Cited by 6 | Viewed by 4057
Abstract
The retina, a tissue of the central nervous system, is vital for vision as its photoreceptors capture light and transform it into electrical signals, which are further processed before they are sent to the brain to be interpreted as images. The retina is [...] Read more.
The retina, a tissue of the central nervous system, is vital for vision as its photoreceptors capture light and transform it into electrical signals, which are further processed before they are sent to the brain to be interpreted as images. The retina is unique in that it is continuously exposed to light and has the highest metabolic rate and demand for energy amongst all the tissues in the body. Consequently, the retina is very susceptible to oxidative stress. VDAC, a pore in the outer membrane of mitochondria, shuttles metabolites between mitochondria and the cytosol and normally protects cells from oxidative damage, but when a cell’s integrity is greatly compromised it initiates cell death. There are three isoforms of VDAC, and existing evidence indicates that all three are expressed in the retina. However, their precise localization and function in each cell type is unknown. It appears that most retinal cells express substantial amounts of VDAC2 and VDAC3, presumably to protect them from oxidative stress. Photoreceptors express VDAC2, HK2, and PKM2—key proteins in the Warburg pathway that also protect these cells. Consistent with its role in initiating cell death, VDAC is overexpressed in the retinal degenerative diseases retinitis pigmentosa, age related macular degeneration (AMD), and glaucoma. Treatment with antioxidants or inhibiting VDAC oligomerization reduced its expression and improved cell survival. Thus, VDAC may be a promising therapeutic candidate for the treatment of these diseases. Full article
Show Figures

Figure 1

34 pages, 508 KB  
Review
Huntington’s Disease: Complex Pathogenesis and Therapeutic Strategies
by Huichun Tong, Tianqi Yang, Shuying Xu, Xinhui Li, Li Liu, Gongke Zhou, Sitong Yang, Shurui Yin, Xiao-Jiang Li and Shihua Li
Int. J. Mol. Sci. 2024, 25(7), 3845; https://doi.org/10.3390/ijms25073845 - 29 Mar 2024
Cited by 77 | Viewed by 15648
Abstract
Huntington’s disease (HD) arises from the abnormal expansion of CAG repeats in the huntingtin gene (HTT), resulting in the production of the mutant huntingtin protein (mHTT) with a polyglutamine stretch in its N-terminus. The pathogenic mechanisms underlying HD are complex and [...] Read more.
Huntington’s disease (HD) arises from the abnormal expansion of CAG repeats in the huntingtin gene (HTT), resulting in the production of the mutant huntingtin protein (mHTT) with a polyglutamine stretch in its N-terminus. The pathogenic mechanisms underlying HD are complex and not yet fully elucidated. However, mHTT forms aggregates and accumulates abnormally in neuronal nuclei and processes, leading to disruptions in multiple cellular functions. Although there is currently no effective curative treatment for HD, significant progress has been made in developing various therapeutic strategies to treat HD. In addition to drugs targeting the neuronal toxicity of mHTT, gene therapy approaches that aim to reduce the expression of the mutant HTT gene hold great promise for effective HD therapy. This review provides an overview of current HD treatments, discusses different therapeutic strategies, and aims to facilitate future therapeutic advancements in the field. Full article
18 pages, 1083 KB  
Review
The Impact and Effects of Host Immunogenetics on Infectious Disease Studies Using Non-Human Primates in Biomedical Research
by Neil Berry, Edward T. Mee, Neil Almond and Nicola J. Rose
Microorganisms 2024, 12(1), 155; https://doi.org/10.3390/microorganisms12010155 - 12 Jan 2024
Cited by 5 | Viewed by 3028
Abstract
Understanding infectious disease pathogenesis and evaluating novel candidate treatment interventions for human use frequently requires prior or parallel analysis in animal model systems. While rodent species are frequently applied in such studies, there are situations where non-human primate (NHP) species are advantageous or [...] Read more.
Understanding infectious disease pathogenesis and evaluating novel candidate treatment interventions for human use frequently requires prior or parallel analysis in animal model systems. While rodent species are frequently applied in such studies, there are situations where non-human primate (NHP) species are advantageous or required. These include studies of animals that are anatomically more akin to humans, where there is a need to interrogate the complexity of more advanced biological systems or simply reflect susceptibility to a specific infectious agent. The contribution of different arms of the immune response may be addressed in a variety of NHP species or subspecies in specific physiological compartments. Such studies provide insights into immune repertoires not always possible from human studies. However, genetic variation in outbred NHP models may confound, or significantly impact the outcome of a particular study. Thus, host factors need to be considered when undertaking such studies. Considerable knowledge of the impact of host immunogenetics on infection dynamics was elucidated from HIV/SIV research. NHP models are now important for studies of emerging infections. They have contributed to delineating the pathogenesis of SARS-CoV-2/COVID-19, which identified differences in outcomes attributable to the selected NHP host. Moreover, their use was crucial in evaluating the immunogenicity and efficacy of vaccines against COVID-19 and establishing putative correlates of vaccine protection. More broadly, neglected or highly pathogenic emerging or re-emergent viruses may be studied in selected NHPs. These studies characterise protective immune responses following infection or the administration of candidate immunogens which may be central to the accelerated licensing of new vaccines. Here, we review selected aspects of host immunogenetics, specifically MHC background and TRIM5 polymorphism as exemplars of adaptive and innate immunity, in commonly used Old and New World host species. Understanding this variation within and between NHP species will ensure that this valuable laboratory source is used most effectively to combat established and emerging virus infections and improve human health worldwide. Full article
(This article belongs to the Special Issue Emerging Infectious Diseases in Humans and Animals)
Show Figures

Figure 1

Back to TopTop